RAC 5.59% $1.70 race oncology ltd

Ann: Race Strategic Update August 2023, page-590

  1. 866 Posts.
    lightbulb Created with Sketch. 1051
    Thanks II for the good reminder for everyone !

    Kyprolis current annual sale world wide sales $USD1.378 bill, and increasing YoY ...

    https://hotcopper.com.au/data/attachments/5742/5742486-5e49635536e98758fb255a71a2e302f1.jpg

    accounting for 5 % of Amagen's total product sales

    https://hotcopper.com.au/data/attachments/5742/5742499-6d388a80198d03301ace360b90eb4921.jpg

    for those new investors not familair with Race's discovery of cardio protection, here
    https://raceoncology.com/expanded-heart-protection-discovery-for-zantrene/

    https://hotcopper.com.au/data/attachments/5742/5742505-543f8eedd92c133048951eae81d4a863.jpg

    Then go re-read the Triangle report to understand its conclusions of the value of bisantrene are not so fancical !

    https://raceoncology.com/april-2023-update/

 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.